Stock·NASDAQ·Industrials
AeroVironment, Inc. (AVAV)
- Market cap
- $6.44B
- Dividend yield
- None
- Street target
- $210.00median of 24 analysts
- 52-week range
- $113.15 $408.25
AVAV stock forecast today
Where AVAV stands today, and what CleaRank Financial AI makes of it.
AVAV at a glance
AeroVironment, Inc. (AVAV): Sell, 33/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($143.54 and $189.06).
- Earnings AVAV beat estimates in 3 of its last 8 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $7.7M and made no open-market purchases over the last 18 months.
Figures as of October 27, 2026.
CleaRank Financial AI
CleaRank rates AeroVironment, Inc. (AVAV) Sell, with a model score of 33/100.
The analysts' outlook lifts the score most: 19 of 24 analysts rate it a buy and the median target is 65.7% above the price. The trend holds it back most: the price is 32.97% below its 200-day average and 11.71% below its 50-day average, and the 50-day average is 24.08% below the 200-day. The 50-day average stands at $143.54 and the 200-day at $189.06. Over the past year the price fell 66.66%.
Only on CleaRank
Figures we compute ourselves from AVAV's own price, earnings and insider-filing history. Tap one to see it in context.
AVAV stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $126.73 is 11.7% below the 50-day simple moving average of $143.54.Price above its 200-day average ›
The price is 33.0% below the 200-day simple moving average of $189.06.50-day average above the 200-day ›
The 50-day average ($143.54) is 24.1% below the 200-day average ($189.06), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 5% of its 52-week range, between $113.15 and $408.25.
AVAV share price
Pick a period: each tab shows how far AVAV has moved over it, to the last close.
Today's trading
Where AVAV sits inside today's range and its 52-week range.
AVAV fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S below the sector median ›
The price-to-sales ratio of 3.26 is 18.6% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was -$352.4M on revenue of $2.0B, a net margin of -17.8%.Beat estimates in most recent reports ›
AVAV beat the EPS estimate in 3 of its last 8 reports.
Key statistics
The headline figures for AVAV.
As of October 27, 2026, AVAV trades at $126.73, with a market value of $6.44B.
What the numbers say
CleaRank Financial AI's reading of AVAV's valuation, growth and risks.
AVAV has no usable P/E, because its earnings per share over the last 12 months are negative, which makes the ratio not meaningful. To put its size in context, the market capitalisation is $6.4B.
AVAV is unprofitable at present: its net margin is -17.8% and its operating margin is -2.27%. Return on equity stands at -4.60%, below the sector median of 17.8%. Its debt-to-equity ratio is 0.19.
AVAV's most recent quarterly report, dated September 9, 2026, beat the estimate by 136.00%: the company reported $0.59 a share against an estimate of $0.25. In the first session after the report, the share price rose 4.45%.
Over its last 8 reports, AVAV topped the estimate 3 times, and every one of those beats was followed by a gain the next day. Of the 3 reports before the latest, the largest reaction came after the June 29, 2026 report, which beat the estimate by 25.17% while the stock rose 18.76%. The consensus EPS estimate stands at $3.26 for this fiscal year and $4.41 for next, a decline of 1.5% for the current year.
Daily swings are the main risk to plan around. On an average session AVAV moves 2.47%, and its beta against the S&P 500 is 1.36. The trend stays against holders until the price gets back above its moving averages. The price is 68.96% below the 52-week high of $408.25. Over the last 18 months insiders sold $7.7M of stock and bought none on the open market. Those sales are often planned ahead, so they carry less weight than purchases would.
AVAV against the Industrials sector
How AVAV compares with the median Industrials stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, AVAV trades at 3.26x, -19% versus the sector average of 4.00x.
Return vs XLI: Since May 15, 2025, AVAV has lost 23.4% against a gain of 18.1% for XLI.
Performance against XLI
AVAV and the Industrials sector fund over the same days.
Revenue and earnings
How much AVAV sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to April 30, 2026); AVAV reported again on September 9, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 140.9% in FY2026 to $2.0B, from $821M a year earlier.
Profit margin: The net margin was -13.4% in FY2026, down from 5.3% the year before.
Loss-making: AVAV lost $265M in FY2026.
Earnings reality check
Did AVAV beat what analysts expected, and how did the stock react?
Earnings record: AVAV beat the analyst estimate in 3 of the last 8 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Sep 9, 2026after close | $0.25 | $0.59 | +136.00% | +4.45% | +11.12% |
| Jun 29, 2026after close | $1.47 | $1.84 | +25.17% | +18.76% | +16.93% |
| Mar 10, 2026after close | $0.69 | $0.64 | -7.25% | -6.25% | +0.42% |
| Dec 9, 2025after close | $0.79 | $0.44 | -44.30% | -12.85% | -16.62% |
| Sep 9, 2025after close | $0.34 | $0.32 | -5.88% | +6.95% | +15.10% |
| Jun 24, 2025after close | $1.39 | $1.61 | +15.83% | +21.55% | +30.59% |
| Mar 4, 2025after close | $0.72 | $0.30 | -58.33% | -4.38% | -12.61% |
| Dec 4, 2024after close | $0.68 | $0.47 | -30.88% | -15.88% | -21.61% |
As of October 27, 2026, AVAV has beaten the analyst EPS estimate in 3 of its last 8 reported quarters and rose in the first trading session after every one of those beats; its latest report, on September 9, 2026, came in 136.00% above the estimate and the stock moved +4.45% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AVAV AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 41.6, in neutral territory.RSI above 50 ›
An RSI of 41.6 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of AVAV
The score, the reasoning behind it, and what could move the price next.
AeroVironment, Inc. (AVAV) is trending down. At $126.73, the stock sits 11.71% below its 50-day average of $143.54 and 32.97% below its 200-day average of $189.06. Near the bottom of its 52-week range, the price is 12.00% above the low of $113.15, while it is 68.96% below the high of $408.25. The 50-day average is 24.08% below the 200-day, a gap that supports the weak trend rather than cutting against it.
The price is down over each of these periods: 16.65% over the past month, 18.94% over the past three months and 66.66% over the past year. The 14-day RSI of 41.6 is in the neutral zone, and the MACD line is negative.
Earnings beat ›
The September 9, 2026 report beat the EPS estimate by 136.00%, and the share price rose 4.45% in the first session after it.
Source: Earnings report, September 9, 2026New analyst coverage ›
Oppenheimer started coverage at Outperform on October 22, 2026.
Source: Analyst action, Oppenheimer, October 22, 2026New analyst coverage ›
Macquarie started coverage at Outperform on October 16, 2026.
Source: Analyst action, Macquarie, October 16, 2026
- The two closest levels matter most: the 20-day EMA at $129.45 sits above the price, and the 52-week low at $113.15 sits below it.
- A 14-day RSI of 41.6 is neutral, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- The share price rose 4.45% in the first session after the September 9, 2026 report. Across the last 8 reports, AVAV has beaten estimates in 3.
AVAV is in a downtrend, trading below its 50-day and 200-day moving averages ($143.54 and $189.06). A recovery back above the 50-day would be the first sign that the trend is mending. The closest level overhead is the 20-day EMA, at $129.45.
The next level below the price is the 52-week low of $113.15.
Technical indicators
Momentum and trend for AVAV, from its daily closes.
As of October 27, 2026, with AVAV at $126.73, its 14-day RSI is 41.6 (neutral territory), its 50-day simple moving average is $143.54 and its 200-day is $189.06.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What AVAV moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, AVAV's 1-year correlation of daily returns is +0.33 with S&P 500 (SPY), +0.33 with Nasdaq 100 (QQQ), +0.21 with Bitcoin (BTC) and +0.13 with gold (XAU).
AVAV price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
19 of 24 analysts rate it a buy or strong buy, 5 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $210.00 is 65.7% above the price.More buy ratings than three months ago ›
19 of 24 rate it a buy now, against 17 of 20 three months ago.
AVAV Wall Street View
12-month price targets
The price, $126.73, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 22, 2026 | Oppenheimer | Initiates | Outperform |
| Oct 19, 2026 | Citizens | Maintains | Market Outperform |
| Oct 16, 2026 | Macquarie | Initiates | Outperform |
| Oct 9, 2026 | Barclays | Initiates | Equal-Weight |
| Oct 6, 2026 | Rothschild & Co | Initiates | Neutral |
| Sep 16, 2026 | Jefferies | Maintains | Buy |
As of October 27, 2026, 24 Wall Street analysts cover AVAV: 19 rate it a buy or strong buy, 5 a hold and 0 a sell or strong sell. Their 12-month price targets range from $148.57 to $315.00. The median AVAV price target is $210.00, 65.7% above the price of $126.73.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
AVAV trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AVAV trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from AVAV's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AVAV tends to move, against the market and on its own.
AVAV price history and drawdowns
AVAV's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.47% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 71.3%, from October 2025 to October 2026; the price is still 69.1% below that peak.Most 1-year holds ended higher ›
71% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $53,495, against $42,376 in the S&P 500 (SPY).
AVAV Drawdowns & Recovery
As of October 27, 2026, AVAV's worst peak-to-trough fall over the last 10 years with dividends reinvested was -71.3% (October 2025 to October 2026); it is still 69.1% below that peak, and 71% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AVAV in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: AVAV beat the S&P 500 over this period: $53,495 against $42,376.
A $10,000 investment in AVAV in October 2016 would be worth about $53,495 today with dividends reinvested, compared with about $42,376 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AVAV, and which have not.
Strongest month, January: an average of +8.02%, up in 6 of 10 years.
Weakest month, December: an average of -7.74%, up in 2 of 10 years.
This month, October: has averaged +6.71%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, AVAV's strongest calendar month has been January (average +8.02%, up in 6 of 10 years) and its weakest December (average -7.74%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
AVAV stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AVAV, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in AVAV today could grow to about $14,609 by 2030 in the base case, with a 90th-percentile outcome near $52,627 and a 10th-percentile outcome around $4,055. Projections are statistical simulations, not guarantees.
AVAV Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $185 for AVAV by 2030 in the base case, from $127 today (1.5x over 4 years). The 10th-percentile path ends near $51.39. These are outcomes of a Monte Carlo simulation run on AVAV's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $73.41 | $139 | $264 | |
| 2028 | $61.89 | $153 | $379 | |
| 2029 | $55.50 | $168 | $511 | |
| 2030 | $51.39 | $185 | $667 |
Method: a lognormal simulation of AVAV's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. AVAV is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
AVAV insider trading
What the people running the company have bought and sold.
AVAV insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought AVAV shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 27, 2026, AVAV insiders reported 24 open-market sales worth $7.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Stephen F Page
Director
|
Sell | 250 | $38.1K |
| Sep 15, 2026 | Brian Charles Shackley
Officer
|
Sell | 100 | $15.2K |
| Sep 14, 2026 | Michael D. Ruppert
Director
|
Grant | 957 | - |
| Aug 17, 2026 | Stephen F Page
Director
|
Sell | 250 | $48.0K |
| Aug 14, 2026 | Brian Charles Shackley
Officer
|
Sell | 205 | $41.4K |
| Jul 15, 2026 | Brian Charles Shackley
Officer
|
Sell | 300 | $42.9K |
| Jul 15, 2026 | Stephen F Page
Director
|
Sell | 248 | $35.5K |
| Jul 2, 2026 | Melissa Ann Brown
Officer
|
Grant | 1.7K | - |
| Jul 2, 2026 | Charles Thomas Burbage
Director
|
Grant | 1.2K | - |
| Jul 2, 2026 | Phillip S Davidson
Director
|
Grant | 1.2K | - |
| Jul 2, 2026 | Cindy Kay Lewis
Director
|
Grant | 1.3K | - |
| Jul 2, 2026 | Mary Beth Long
Director
|
Grant | 1.2K | - |
| Jul 2, 2026 | William Lynn III
Director
|
Grant | 892 | - |
| Jul 2, 2026 | Clum Mary Elizabeth Mcdaniel
Officer
|
Grant | 1.2K | - |
| Jul 2, 2026 | Edward R Muller
Director
|
Grant | 1.4K | - |
| Jul 2, 2026 | Wahid Nawabi
Chief Executive Officer
|
Grant | 15.8K | $13.6K |
| Jul 2, 2026 | Stephen F Page
Director
|
Grant | 1.2K | - |
| Jul 2, 2026 | Brian Charles Shackley
Officer
|
Grant | 698 | - |
| Jul 2, 2026 | Robert Fendlay Smith
Chief Operating Officer
|
Grant | 2.0K | - |
| Jul 2, 2026 | Trace E Stevenson
Officer
|
Grant | 2.4K | - |
| Jul 2, 2026 | Joseph L. Votel
Director
|
Grant | 1.3K | - |
| Jul 2, 2026 | Sean Thomas Woodward
Chief Financial Officer
|
Grant | 2.2K | $13.6K |
| Jun 29, 2026 | Melissa Ann Brown
Officer
|
Grant | 9.2K | - |
| Jun 29, 2026 | Wahid Nawabi
Chief Executive Officer
|
Grant | 57.7K | - |
| Jun 29, 2026 | Brian Charles Shackley
Officer
|
Grant | 2.4K | - |
| Jun 29, 2026 | Trace E Stevenson
Officer
|
Grant | 4.8K | - |
| Jun 29, 2026 | Sean Thomas Woodward
Chief Financial Officer
|
Grant | 2.4K | - |
| Jun 15, 2026 | Stephen F Page
Director
|
Sell | 250 | $43.6K |
| May 15, 2026 | Stephen F Page
Director
|
Sell | 250 | $40.6K |
| Apr 15, 2026 | Stephen F Page
Director
|
Sell | 250 | $49.3K |
| Apr 13, 2026 | Robert Fendlay Smith
Chief Operating Officer
|
Grant | 1.8K | $349.9K |
| Mar 16, 2026 | Stephen F Page
Director
|
Sell | 250 | $53.1K |
| Mar 16, 2026 | Brian Charles Shackley
Officer
|
Sell | 200 | $42.5K |
| Mar 16, 2026 | Brian Charles Shackley
Officer
|
Grant | 707 | - |
| Mar 10, 2026 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 396 | $88.9K |
| Mar 2, 2026 | Stephen F Page
Director
|
Sell | 250 | $52.1K |
| Feb 19, 2026 | Stephen F Page
Director
|
Sell | 250 | $68.8K |
| Feb 17, 2026 | Stephen F Page
Director
|
Sell | 500 | $127.5K |
| Feb 10, 2026 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 879 | $235.2K |
| Jan 15, 2026 | Stephen F Page
Director
|
Sell | 1.0K | $377.6K |
| Jan 12, 2026 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 999 | $367.2K |
| Dec 30, 2025 | Brian Charles Shackley
Officer
|
Sell | 200 | $50.2K |
| Dec 10, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 511 | $127.4K |
| Nov 10, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 513 | $170.0K |
| Oct 10, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 998 | $398.9K |
| Oct 6, 2025 | Trace E Stevenson
Officer
|
Sell | 1.7K | $654.2K |
| Jul 16, 2025 | Wahid Nawabi
Chief Executive Officer
|
Sell | 17.3K | $4.6M |
| Jun 30, 2025 | Wahid Nawabi
Chief Executive Officer
|
Grant | 159 | $45.3K |
| Jun 30, 2025 | Bradley Dean Truesdell
Chief Operating Officer
|
Grant | 70 | $19.9K |
| Jun 27, 2025 | Melissa Ann Brown
Officer
|
Grant | 1.1K | $314.5K |
| Jun 27, 2025 | Charles Thomas Burbage
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Phillip S Davidson
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | James William Ferguson III
Officer
|
Grant | 872 | $242.5K |
| Jun 27, 2025 | Cindy Kay Lewis
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Mary Beth Long
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Grant | 1.8K | $498.0K |
| Jun 27, 2025 | Edward R Muller
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Wahid Nawabi
Chief Executive Officer
|
Grant | 9.9K | $2.8M |
| Jun 27, 2025 | Stephen F Page
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Brian Charles Shackley
Officer
|
Grant | 387 | $107.6K |
| Jun 27, 2025 | Trace E Stevenson
Officer
|
Grant | 2.2K | $606.5K |
| Jun 27, 2025 | Trace E Stevenson
Officer
|
Grant | 1.2K | - |
| Jun 27, 2025 | Bradley Dean Truesdell
Chief Operating Officer
|
Grant | 688 | $191.3K |
| Jun 27, 2025 | Joseph L. Votel
Director
|
Grant | 609 | $169.3K |
| Jun 24, 2025 | Melissa Ann Brown
Officer
|
Grant | 7.9K | - |
| Jun 24, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Grant | 17.1K | - |
| Jun 24, 2025 | Wahid Nawabi
Chief Executive Officer
|
Grant | 39.9K | - |
| Jun 24, 2025 | Brian Charles Shackley
Officer
|
Grant | 2.3K | - |
| Jun 24, 2025 | Trace E Stevenson
Officer
|
Grant | 3.4K | - |
| Jun 6, 2025 | Melissa Ann Brown
Officer
|
Grant | 523 | $99.8K |
| Jun 6, 2025 | Brian Charles Shackley
Officer
|
Grant | 785 | $149.8K |
| Jun 6, 2025 | Bradley Dean Truesdell
Chief Operating Officer
|
Grant | 130 | $24.8K |
Source: TwelveData, from SEC Form 4 filings
AVAV stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.